Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

Recombinant human erythropoietin (rHuEpo) has been used successfully in the treatment of cancer-related anemia. Clinical observations with several patients with multiple-myeloma treated with rHuEpo has shown, in addition to the improved quality of life, a longer survival than expected, considering t...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

-д хэвлэсэн:	Proc Natl Acad Sci U S A
Үндсэн зохиолчид:	Mittelman, Moshe, Neumann, Drorit, Peled, Alpha, Kanter, Pazit, Haran-Ghera, Nechama
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	National Academy of Sciences 2001
Нөхцлүүд:	Biological Sciences
Онлайн хандалт:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC33184/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11309490/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.081275298
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!